[Long-term treatment with an imidazoline derivative (DS 103--282) (author's transl)]
[Article in
German]
- PMID: 547191
Item in Clipboard
[Long-term treatment with an imidazoline derivative (DS 103--282) (author's transl)]
[Article in
German]
Nervenarzt.
1979 Dec.
No abstract available
Similar articles
-
[Long-term treatment of spasticity with tisanidine (sirdulad) in 2 cases of multiple sclerosis].Wiad Lek. 1987 Dec 15;40(24):1711-4. Wiad Lek. 1987. PMID: 3451608 Polish. No abstract available.
-
[Clinical experiences with a new muscle relaxant (DS 103-282 Sandoz) (author's transl)].Nervenarzt. 1977 Jul;48(7):355-8. Nervenarzt. 1977. PMID: 333301 Clinical Trial. German. No abstract available.
-
A double-blind comparative trial of new muscle relaxant, tizanidine (DS 103-282), and baclofen in the treatment of chronic spasticity in multiple sclerosis.Curr Med Res Opin. 1981;7(6):374-83. Curr Med Res Opin. 1981. PMID: 7016449 Clinical Trial.
-
Current pharmacologic treatment of multiple sclerosis symptoms.West J Med. 1996 Nov;165(5):313-7. West J Med. 1996. PMID: 8993211 Free PMC article. Review.
-
Therapeutic and symptomatic treatment of multiple sclerosis.Phys Med Rehabil Clin N Am. 1998 Aug;9(3):587-601, vi-vii. Phys Med Rehabil Clin N Am. 1998. PMID: 9894111 Review.
Cited by
-
Anti-spasticity agents for multiple sclerosis.Cochrane Database Syst Rev. 2000;2003(4):CD001332. doi: 10.1002/14651858.CD001332. Cochrane Database Syst Rev. 2000. Update in: Cochrane Database Syst Rev. 2001;(4):CD001332. doi: 10.1002/14651858.CD001332. PMID: 11034714 Free PMC article. Updated.
-
Tizanidine. A review of its pharmacology, clinical efficacy and tolerability in the management of spasticity associated with cerebral and spinal disorders.Drugs. 1997 Mar;53(3):435-52. doi: 10.2165/00003495-199753030-00007. Drugs. 1997. PMID: 9074844 Review.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources